Alkem Laboratories Limited, a pharmaceutical company, engages in the development, manufacture, and sale of pharmaceutical and nutraceutical products in India and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, dermatology, cardiac, respiratory, gastro-intestinal, central nervous system, oncology, urology, and gynaecology, as well as vitamins, minerals, and nutrients; and pain analgesic, anti-diabetic, and neurology products. It also provides pregnancy detection kits and condoms. The company was incorporated in 1973 and is headquartered in Mumbai, India.
Alkem Laboratories Dividend Announcement
• Alkem Laboratories announced a semi annually dividend of ₹5.00 per ordinary share which will be made payable on 2024-09-29. Ex dividend date: 2024-08-09
• Alkem Laboratories annual dividend for 2024 was ₹40.00
• Alkem Laboratories annual dividend for 2023 was ₹25.00
• Alkem Laboratories's trailing twelve-month (TTM) dividend yield is 0.73%
• Alkem Laboratories's dividend growth over the last five years (2018-2023) was 13.97% year
Alkem Laboratories Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-08-09 | ₹5.00 | semi annually | 2024-09-29 |
2024-02-16 | ₹35.00 | semi annually | 2024-03-01 |
2023-08-10 | ₹10.00 | semi annually | 2023-09-24 |
2023-02-17 | ₹15.00 | semi annually | 2023-03-01 |
2022-08-08 | ₹4.00 | semi annually | 2022-09-24 |
2022-02-10 | ₹30.00 | semi annually | 2022-03-06 |
2021-08-09 | ₹5.00 | semi annually | 2021-09-19 |
2021-02-11 | ₹25.00 | semi annually | 2021-03-07 |
2020-08-10 | ₹3.00 | semi annually | 2020-09-17 |
2020-02-13 | ₹22.00 | semi annually | 2020-03-08 |
2019-08-19 | ₹8.00 | semi annually | 2019-09-26 |
2019-02-15 | ₹8.00 | semi annually | 2019-03-10 |
2018-08-23 | ₹7.00 | semi annually | 2018-09-30 |
2018-02-16 | ₹6.00 | semi annually | 2018-03-11 |
2017-08-31 | ₹9.00 | semi annually | 2017-10-01 |
2016-11-23 | ₹6.00 | semi annually | 2016-11-28 |
2016-03-18 | ₹9.70 | semi annually | 2016-07-01 |
Alkem Laboratories Dividend per year
Alkem Laboratories Dividend growth
Alkem Laboratories Dividend Yield
Alkem Laboratories current trailing twelve-month (TTM) dividend yield is 0.73%. Interested in purchasing Alkem Laboratories stock? Use our calculator to estimate your expected dividend yield:
Alkem Laboratories Financial Ratios
Alkem Laboratories Dividend FAQ
Other factors to consider when evaluating Alkem Laboratories as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Alkem Laboratories stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Alkem Laboratories's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Alkem Laboratories publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Alkem Laboratories distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Alkem Laboratories are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Alkem Laboratories sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Alkem Laboratories distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Alkem Laboratories declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Alkem Laboratories's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Alkem Laboratories's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.